Wan Yus Haniff Wan Isa

Wan Yus Haniff Wan Isa

Auto-generated profile, based on publicly available information

Wan Yus Haniff Wan Isa

Department of Internal Medicine, School of Medical Sciences, Universiti Sains Malaysia, Health Campus, Kubang Kerian, Kelantan, Malaysia

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
NPNur Najwa Pahimi
Nur Najwa Pahimi
ARAida Rasool
Aida Rasool
ZSZulkefli Bin Sanip
Zulkefli Bin Sanip
NBNUR ADILAH BINTI BOKTI
NUR ADILAH BINTI BOKTI
ZYZurkurnai Yusof
Zurkurnai Yusof
WIW. Yus Haniff W. Isa
W. Yus Haniff W. Isa
Approximately half of all women presenting to the emergency department with angina chest pain do not have obstructive coronary artery disease (CAD) on coronary angiography. This condition is termed non-obstructive coronary artery disease (NOCAD), and includes ischemia with no obstructive coronary artery disease (INOCA) and myocardial infarction with non-obstructive coronary arteries (MINOCA). Oxidative stress has been reported to be involved in the development and progression of CAD. However, a scarcity of studies has assessed a correlation between oxidative stress and NOCAD. Thus, a literature review was performed of available reports on the role of oxidative stress in NOCAD. Possible mechanisms involved in oxidative stress that may contribute to NOCAD were identified and evaluated. A key finding of this literature review was that oxidative stress caused vasoconstriction and endothelial damage, and this results in coronary microvascular dysfunction and vasospasm, which, in turn, lead to the pathogenesis of NOCAD.

1 January 2011 in Internal Medicine
Verified
Journal Article
Open access
PDF file
WIWan Yus Haniff Wan Isa
Wan Yus Haniff Wan Isa
KDKamaliah M Daud
Kamaliah M Daud
We report a case of renal tubular acidosis (RTA) in a patient with HIV infection and AIDS. A 33-year-old HIV-positive man with Hepatitis C and tuberculous lymphadenitis was admitted due to deep venous thrombosis and generalized muscle weakness. He had never received anti-retroviral medication. The blood gases and serum electrolytes showed hyperchloremic normal anion gap metabolic acidosis with severe hypokalemia and alkaline urine. Diagnosis of distal RTA was made. His renal function and serum globulin level remained within normal range throughout his illness. Clinicians should be alert to renal tubular disorders in HIV/AIDS patients even in the absence of anti-retroviral therapy or hypergammaglobulinemic state.

28 February 2025 in Journal of Asian Pacific Society of Cardiology
Verified
Journal Article
Open access
WAWan Azman Wan Ahmad
Wan Azman Wan Ahmad
AGAbdul Kahar Abdul Ghapar
Abdul Kahar Abdul Ghapar
AGAzmee Mohd Ghazi
Azmee Mohd Ghazi
HAHafisyatul Aiza Zainal Abidin
Hafisyatul Aiza Zainal Abidin
NRNoel Thomas Ross
Noel Thomas Ross
AFAlan Yean Yip Fong
Alan Yean Yip Fong
Background: Three main phenotypes describe heart failure (HF) according to left ventricular ejection fraction (LVEF). This study aims to describe the characteristics, management and outcomes of hospitalised patients with HF categorised by LVEF. Methods: The Malaysian National Heart Failure (MY-HF) Registry is a 3-year prospective, observational study of patients admitted for acute HF. This analysis includes 2,651 patients categorised into: HF with reduced ejection fraction (HFrEF; LVEF ≤40%), HF with mildly reduced ejection fraction (HFmrEF; LVEF 41−49%) and HF with preserved ejection fraction (HFpEF; LVEF ≥50%). Hospital readmission and mortality outcomes at 30 days and 1 year were examined. Results: The HFrEF subgroup represented the largest proportion of patients (66.2%), followed by HFpEF (22.1%) and HFmrEF (11.7%). The HFpEF subgroup was older (mean age 65.3 ± 13.3 years), had the highest proportion of females (53.5%) and had more patients with de novo HF at admission than the HFrEF subgroup (41.9% versus 31.4%). Comorbidities, such as hypertension, AF and chronic kidney disease, were more prevalent in the HFpEF than HFrEF subgroup. Conversely, more HFrEF patients had ischaemic heart disease and elevated N-terminal pro B-type natriuretic peptide levels (≥1,000 pg/ml). Similar 30-day and 1-year outcome rates were observed across the subgroups except for lower 30-day hospital readmission (p=0.024) and 1-year mortality (p=0.005) in the HFpEF subgroup. Older age (>60 years) and New York Heart Association class III–IV increased 1-year readmission risk. Conclusion: The MY-HF Registry highlighted high 1-year mortality in patients with HF, especially those with advanced NYHA class or chronic kidney disease. This suggests potential areas for improvement in HF management, including medication regimens, adherence and comorbidity management. Future research exploring these factors could significantly impact clinical practice and patient outcomes.

8 April 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
AAAmilia Aminuddin
Amilia Aminuddin
NRNina Diyana Rusanuar
Nina Diyana Rusanuar
MLMD RIZMAN MD LAZIN MD LAZIM
MD RIZMAN MD LAZIN MD LAZIM
AUAzizah Ugusman
Azizah Ugusman
IRIzzat Zulhilmi Abd Rahman
Izzat Zulhilmi Abd Rahman
WIWan Yus Haniff Wan Isa
Wan Yus Haniff Wan Isa
Background/Objectives: Vascular function measurements, including central parameters [pulse wave velocity (PWV) and augmentation index (AI)], as well as peripheral measures [finger photoplethysmography fitness index (PPGF)], have been introduced to detect early vascular damage associated with coronary artery disease (CAD) risk factors. This study aimed to compare peripheral and central vascular function marker levels among subjects with hypertension (HPT), dyslipidemia, and obesity. We also aimed to determine the relationship between these markers and CAD risk factors among these groups. Methods: A total of 320 subjects including healthy individuals and those with CAD risk factors were recruited. Peripheral vascular function was assessed using the PPGF, whereas central vascular markers included measurements of PWV and AI. The Framingham risk score (FRS) was calculated using an online calculator. Results: The mean age of the subjects was 33.73 ± 7.29 years. PWV and AI were significantly higher in HPT subjects (8.03 ± 1.40 m/s and 21.90% ± 10.57%) than the control. PPGF levels showed no significant differences between the groups. PWV was associated with FRS in the HPT and dyslipidemia groups, whereas AI was associated with FRS in the obese group. PPGF showed associations with PWV and AI in the dyslipidemia group. Conclusions: PWV and AI serve as robust macrovascular markers indicating arterial stiffness and systemic vascular resistance linked to CAD risk, while PPGF, as a microvascular marker, offers valuable insights into early endothelial dysfunction and microcirculatory anomalies, especially in dyslipidemia subjects.

31 December 2024 in Malaysian Journal of Medical Sciences
Verified
Journal Article
Open access
ZSZulkefli Sanip
Zulkefli Sanip
ARAida Hanum Ghulam Rasool
Aida Hanum Ghulam Rasool
NPNurnajwa Pahimi
Nurnajwa Pahimi
NBNur Adilah Bokti
Nur Adilah Bokti
ZYZurkurnai Yusof
Zurkurnai Yusof
WIW Yus Haniff W Isa
W Yus Haniff W Isa
Background: Non-obstructive coronary artery disease (NOCAD) is a condition in stable patients that experience angina despite not having significant coronary obstructive lesion. Knowledge on the role of certain biomarkers in patients with NOCAD is still limited. This study aimed to evaluate the roles of inflammation and adhesion molecules in the development of NOCAD. The correlations between the peripheral and coronary levels of the inflammatory biomarkers and adhesion molecules were also investigated. Methods: In this cross-sectional study, symptomatic angina patients scheduled for coronary angiograms were recruited and separated into obstructive coronary artery disease (OCAD) and NOCAD groups based on those angiograms. Peripheral and coronary blood samples were taken to measure inflammation biomarkers [high sensitivity C-reactive protein (hsCRP) and growth differentiation factor 15 (GDF-15]), and adhesion molecules [vascular cell adhesion molecule-1 (VCAM-1)]. Subjects without angina symptoms were recruited for the control group. Results: The hsCRP, GDF-15, and VCAM-1 levels were higher in the OCAD and NOCAD groups than in the control group. VCAM-1 levels successfully predicted the incidence of NOCAD [p = 0.010, area under the curve (AUC) = 0.716]. All biomarkers’ levels in the peripheral and coronary blood were correlated in OCAD and NOCAD patients (p < 0.001). Conclusion: Elevated levels of the hsCRP, GDF-15, and VCAM-1 were found with NOCAD, despite the absent of significant coronary obstruction. VCAM-1 successfully predicted NOCAD and may thus serve as an early NOCAD biomarker. Significant correlations of hsCRP, GDF-15, and VCAM-1 level in peripheral and coronary blood indicate that the peripheral levels of these biomarkers reflect the levels and changes that occur at the coronary level.

1 December 2021 in International Journal of Cardiology
Verified
Journal Article
Closed access
AHA. Henry
A. Henry
CLC.Y. Lee
C.Y. Lee
WHW.Y. Haniff
W.Y. Haniff
WIW. Isa
W. Isa
MMMohd Sapawi Mohamed
Mohd Sapawi Mohamed
GQG.T. Queck
G.T. Queck